Flibanserin for sexual dysfunctions, psychological

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 11 registered trials.

Why this status

  1. 4 Aug 2006: Trial registered, NCT00360243
  2. 4 Aug 2006: Trial registered, NCT00360555
  3. 1 Mar 2007: Trial registered, NCT00441558
  4. 28 Jan 2008: Trial registered, NCT00601367
  5. 16 Oct 2009: Trial registered, NCT00996164
  6. 16 Oct 2009: Trial registered, NCT00996372
  7. 29 Dec 2009: Trial registered, NCT01040208
  8. 28 Jan 2010: Trial registered, NCT01057901
  9. 14 Apr 2010: Trial registered, NCT01103362
  10. 25 Aug 2010: Trial registered, NCT01188603

The trials

NCT00360243: 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA

State
Completed
Phase
Phase 3
People
1,385 taking part
Started
Jul 2006
Primary completion
Apr 2008
Arms
flibanserin 25 mg b.i.d, flibanserin 50mg qhs, flibanserin 50mg b.i.d.
Results
Posted on the registry
  1. 4 Aug 2006: Trial registered
  2. 27 Jun 2016: Trial results posted

NCT00360555: Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

State
Completed
Phase
Phase 3
People
1,584 taking part
Started
Jul 2006
Primary completion
Mar 2008
Arms
flibanserin, flibanserin 50mg
Results
Posted on the registry
  1. 4 Aug 2006: Trial registered
  2. 27 Jun 2016: Trial results posted

NCT00441558: A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

State
Stopped early
Phase
Phase 3
People
1,723 taking part
Started
Feb 2007
Primary completion
Aug 2009
Arms
flibanserin
Results
Posted on the registry
  1. 1 Mar 2007: Trial registered
  2. 13 Jun 2014: Trial results posted

NCT00601367: Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder

State
Completed
Phase
Phase 3
People
480 taking part
Started
Jan 2008
Primary completion
Oct 2009
Arms
flibanserin flexible dose
Results
Posted on the registry
  1. 28 Jan 2008: Trial registered
  2. 20 Jun 2014: Trial results posted

NCT00996164: Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

State
Completed
Phase
Phase 3
People
1,090 taking part
Started
Oct 2009
Primary completion
Dec 2010
Arms
flibanserin 100 mg
Results
Posted on the registry
  1. 16 Oct 2009: Trial registered
  2. 19 May 2014: Trial results posted

NCT00996372: Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

State
Completed
Phase
Phase 3
People
949 taking part
Started
Oct 2009
Primary completion
Mar 2011
Arms
flibanserin 100mg
Results
Posted on the registry
  1. 16 Oct 2009: Trial registered
  2. 12 Jun 2014: Trial results posted

NCT01040208: 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress

State
Stopped early
Phase
Phase 3
People
111 taking part
Started
Jan 2010
Primary completion
Jan 2011
Arms
flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs
Results
Posted on the registry
  1. 29 Dec 2009: Trial registered
  2. 24 Aug 2016: Trial results posted

NCT01057901: Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America

State
Stopped early
Phase
Phase 3
People
748 taking part
Started
Jan 2010
Primary completion
Jan 2011
Arms
Flibanserin 100 mg
Results
Posted on the registry
  1. 28 Jan 2010: Trial registered
  2. 17 Jun 2014: Trial results posted

NCT01103362: A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder

State
Stopped early
Phase
Phase 3
People
596 taking part
Started
Apr 2010
Primary completion
Jan 2011
Arms
flibanserin 100mg
Results
Posted on the registry
  1. 14 Apr 2010: Trial registered
  2. 12 May 2014: Trial results posted

NCT01188603: Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

State
Completed
Phase
Phase 1
People
24 taking part
Started
Jul 2010
Primary completion
Oct 2010
Arms
flibanserin
Results
Posted on the registry
  1. 25 Aug 2010: Trial registered
  2. 10 Apr 2012: Trial results posted

NCT02714049: Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy

State
Stopped early
Phase
Phase 4
People
23 taking part
Started
25 Jan 2017
Primary completion
18 Jan 2019
Arms
flibanserin
Results
None posted
  1. 21 Mar 2016: Trial registered
  2. 25 Jan 2017: Trial started
  3. 30 Jan 2019: Trial terminated

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Addyi, Ectris, Flibanserin Pill, flibanserin 100 mg dose every evening, flibanserin 100 mg qhs, flibanserin 100mg, flibanserin 50 mg to 100 mg qhs, flibanserin 50mg, flibanserin flexible dose.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.